Global trends in intrahepatic and extrahepatic cholangiocarcinoma incidence from 1993 to 2012

Intrahepatic cholangiocarcinomas (ICCs) and extrahepatic cholangiocarcinomas (ECCs) are highly lethal bile duct tumors. Their incidence can be difficult to estimate because of changes in cancer coding over time. No studies to date have examined their global incidence and trends with high‐quality topography‐ and histology‐specific cancer registry data. Therefore, this study examined ICC and ECC incidence with the Cancer Incidence in Five Continents Plus database.

[1]  C. la Vecchia,et al.  Global trends in mortality from intrahepatic and extrahepatic cholangiocarcinoma. , 2019, Journal of hepatology.

[2]  R. Pfeiffer,et al.  Biliary tract cancer incidence and trends in the United States by demographic group, 1999‐2013 , 2019, Cancer.

[3]  J. Trojan,et al.  Cholangiocarcinoma in Germany: Epidemiologic trends and impact of misclassification , 2018, Liver international : official journal of the International Association for the Study of the Liver.

[4]  R. Sinha,et al.  Body Mass Index, Diabetes and Intrahepatic Cholangiocarcinoma Risk: The Liver Cancer Pooling Project and Meta‐analysis , 2018, The American Journal of Gastroenterology.

[5]  W. Pan-ngum,et al.  Characteristics and outcomes of cholangiocarcinoma by region in Thailand: A nationwide study , 2017, World journal of gastroenterology.

[6]  B. Graubard,et al.  Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: A population-based study in SEER-Medicare , 2017, PloS one.

[7]  M. Agha,et al.  The rising prevalence of obesity: part A: impact on public health , 2017, International journal of surgery. Oncology.

[8]  Xuchen Zhang,et al.  Non-alcoholic fatty liver disease: An expanded review , 2017, World journal of hepatology.

[9]  W. Cheungpasitporn,et al.  Non-alcoholic fatty liver disease as a risk factor for cholangiocarcinoma: a systematic review and meta-analysis , 2017, BMC Gastroenterology.

[10]  Mathieu Laversanne,et al.  International trends in liver cancer incidence, overall and by histologic subtype, 1978–2007 , 2016, International journal of cancer.

[11]  T. Therneau,et al.  Aspirin use and the risk of cholangiocarcinoma , 2016, Hepatology.

[12]  Andrew X. Zhu,et al.  Forty-Year Trends in Cholangiocarcinoma Incidence in the U.S.: Intrahepatic Disease on the Rise , 2016, The oncologist.

[13]  S. Altekruse,et al.  Geographic Variation of Intrahepatic Cholangiocarcinoma, Extrahepatic Cholangiocarcinoma, and Hepatocellular Carcinoma in the United States , 2015, PloS one.

[14]  R. Plentz,et al.  Clinical presentation, risk factors and staging systems of cholangiocarcinoma. , 2015, Best practice & research. Clinical gastroenterology.

[15]  C. Nam,et al.  Hepatitis B virus infection, diabetes mellitus, and their synergism for cholangiocarcinoma development: a case-control study in Korea. , 2015, World journal of gastroenterology.

[16]  T. Laha,et al.  Toward integrated opisthorchiasis control in northeast Thailand: the Lawa project. , 2015, Acta tropica.

[17]  J. Andersen,et al.  Impact of microenvironment and stem-like plasticity in cholangiocarcinoma: molecular networks and biological concepts. , 2015, Journal of hepatology.

[18]  H. El‐Serag,et al.  Secular Trends in the Incidence of Cholangiocarcinoma in the USA and the Impact of Misclassification , 2014, Digestive Diseases and Sciences.

[19]  G. Gores,et al.  Pathogenesis, diagnosis, and management of cholangiocarcinoma. , 2013, Gastroenterology.

[20]  C. la Vecchia,et al.  A comparison of trends in mortality from primary liver cancer and intrahepatic cholangiocarcinoma in Europe. , 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

[21]  H. Thomas,et al.  Rising trends in cholangiocarcinoma: is the ICD classification system misleading us? , 2012, Journal of hepatology.

[22]  M. Manns,et al.  Epidemiological trends in incidence and mortality of hepatobiliary cancers in Germany , 2011, Scandinavian journal of gastroenterology.

[23]  H. El‐Serag,et al.  Risk factors for cholangiocarcinoma , 2011, Hepatology.

[24]  S. Altekruse,et al.  Histological classification of liver and intrahepatic bile duct cancers in SEER registries. , 2011, Journal of registry management.

[25]  Hai-rim Shin,et al.  Descriptive Epidemiology of Cholangiocarcinoma and Clonorchiasis in Korea , 2010, Journal of Korean medical science.

[26]  J. Hebebrand,et al.  [Obesity and overweight]. , 2009, Zeitschrift fur Kinder- und Jugendpsychiatrie und Psychotherapie.

[27]  F. Bray,et al.  Evaluation of data quality in the cancer registry: principles and methods Part II. Completeness. , 2009, European journal of cancer.

[28]  F. Bray,et al.  Evaluation of data quality in the cancer registry: principles and methods. Part I: comparability, validity and timeliness. , 2009, European journal of cancer.

[29]  S. Yun,et al.  Hepatitis B Virus Infection and Intrahepatic Cholangiocarcinoma in Korea: A Case-Control Study , 2008, The American Journal of Gastroenterology.

[30]  B. Sripa,et al.  Opisthorchis viverrini: the carcinogenic human liver fluke. , 2008, World journal of gastroenterology.

[31]  Jiamei Yang,et al.  Risk factors for intrahepatic cholangiocarcinoma: a case-control study in China. , 2008, World journal of gastroenterology.

[32]  Shahid A. Khan,et al.  Re: Impact of classification of hilar cholangiocarcinomas (Klatskin tumors) on incidence of intra- and extrahepatic cholangiocarcinoma in the United States. , 2007, Journal of the National Cancer Institute.

[33]  J. Olsen,et al.  Risk factors for intrahepatic cholangiocarcinoma in a low‐risk population: A nationwide case‐control study , 2007, International journal of cancer.

[34]  T. O'Brien,et al.  Impact of classification of hilar cholangiocarcinomas (Klatskin tumors) on the incidence of intra- and extrahepatic cholangiocarcinoma in the United States. , 2006, Journal of the National Cancer Institute.

[35]  S. Choi,et al.  Cholangiocarcinoma and Clonorchis sinensis infection: a case-control study in Korea. , 2006, Journal of hepatology.

[36]  K. McGlynn,et al.  Risk factors of intrahepatic cholangiocarcinoma in the United States: a case-control study. , 2005, Gastroenterology.

[37]  S. Kubo,et al.  Hepatitis C virus infection as a likely etiology of intrahepatic cholangiocarcinoma , 2004, Cancer Science.

[38]  F. Callea,et al.  Intrahepatic cholangiocarcinoma and hepatitis C and B virus infection, alcohol intake, and hepatolithiasis: a case–control study in Italy , 2001, Cancer Causes & Control.

[39]  P. Jongsuksuntigul,et al.  Opisthorchiasis control in Thailand. , 2003, Acta tropica.

[40]  April Fritz,et al.  International Classification of Diseases for Oncology: ICD-0. , 2000 .

[41]  K. Lillemoe,et al.  Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors. , 1996, Annals of surgery.

[42]  J. Donohue,et al.  Outcomes after curative resections of cholangiocarcinoma. , 1993, Archives of surgery.

[43]  D. Parkin,et al.  Liver cancer in Thailand. I. A case‐control study of cholangiocarcinoma , 1991, International journal of cancer.

[44]  T. Holford.  Understanding the effects of age, period, and cohort on incidence and mortality rates. , 1991, Annual review of public health.

[45]  W. Longmire,et al.  Changing patterns in diagnosis and management of bile duct cancer. , 1990, Annals of surgery.

[46]  M. Hanani,et al.  Biliary Tract , 1987, Current opinion in radiology.

[47]  P. Trott,et al.  International Classification of Diseases for Oncology , 1977 .

[48]  M. Kurihara,et al.  Geographical observation on cancer mortality by selected sites on the basis of standardised death rate. , 1957, Gan.